Major changes (enhance or reduce) in the plasma levels of the progestin have been famous in some cases of co-administration with non-nucleoside reverse transcriptase inhibitors.All through contraceptive counseling and just before initiation of DMPA, information about widespread Unwanted effects like irregular bleeding really should be talked about.